"CEO on the Go" John Beaver
visits with customers and future customers, gathering feedback and
sharing BIOLASE's commitment to minimally-invasive dentistry for
dentists & patients
LAKE
FOREST, Calif., May 24, 2022
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global
leader in dental lasers, shared today that CEO John Beaver will continue his global "CEO on the
Go" customer visit initiative throughout the year.
"The CEO on the Go program was created to get valued feedback
from customers around the world, and help share our vision of
creating kinder, gentler oral health care for dental professionals
and their patients," said BIOLASE President and CEO John Beaver. "This program gives us direct
feedback from dentists globally around how our products are
delivering on this promise, and how we can continue to innovate on
our market-leading dental laser technology. I am always
amazed at the benefits our Waterlase technology provides in
real-life settings. Recently, I watched a dentist use the
Waterlase iPlus to remove 19 veneers in one sitting in less than 30
minutes! Without the laser, the dentist told me this would have
been an-all day affair resulting in much more patient discomfort.
"My travels this year have further confirmed my belief that what
we are incorporating as strategy at BIOLASE today is accelerating
the adoption curve of our game-changing technology.
With over 70% of our U.S. Waterlase sales being to new customers
over the last twelve months, I am convinced that our investment in
education, training and the Waterlase Exclusive Trial Program is
working."
Through the "CEO on the Go" program, John has visited over 50
dentists and their respective teams to date. Over 50 more
visits are planned for the remainder of the year, throughout the
U.S., with visits planned internationally in 2023.
To learn more about the "CEO on the Go" program and watch videos
of these customer visits, go to
biolase.com/ceo-on-the-go.
About BIOLASE
BIOLASE is a medical device company that develops,
manufactures, markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals. BIOLASE's
proprietary laser products incorporate approximately 301 patented
and 32 patent-pending technologies designed to provide biologically
and clinically superior performance with less pain and faster
recovery times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 43,300 laser systems
to date in over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information
on Waterlase iPlus®, Waterlase Express™, and
laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and
LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®,
Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
For further information, please contact:
Investors:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-ceo-shares-vision-for-kindler-gentler-dentistry-with-customers-around-the-world-301553096.html
SOURCE BIOLASE, Inc.